- Home
- AMST vs HOTH Comparison
AMST vs HOTH Comparison
Compare AMST & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMST
- HOTH
- Stock Information
- Founded
- AMST 2017
- HOTH 2017
- Country
- AMST United States
- HOTH United States
- Employees
- AMST N/A
- HOTH N/A
- Industry
- AMST Computer Software: Prepackaged Software
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- AMST Technology
- HOTH Health Care
- Exchange
- AMST Nasdaq
- HOTH Nasdaq
- Market Cap
- AMST 9.5M
- HOTH 8.3M
- IPO Year
- AMST 2020
- HOTH 2019
- Fundamental
- Price
- AMST $2.84
- HOTH $1.30
- Analyst Decision
- AMST
- HOTH Strong Buy
- Analyst Count
- AMST 0
- HOTH 3
- Target Price
- AMST N/A
- HOTH $4.00
- AVG Volume (30 Days)
- AMST 3.4M
- HOTH 2.4M
- Earning Date
- AMST 05-15-2025
- HOTH 05-12-2025
- Dividend Yield
- AMST N/A
- HOTH N/A
- EPS Growth
- AMST N/A
- HOTH N/A
- EPS
- AMST N/A
- HOTH N/A
- Revenue
- AMST $82,544.00
- HOTH N/A
- Revenue This Year
- AMST N/A
- HOTH N/A
- Revenue Next Year
- AMST N/A
- HOTH N/A
- P/E Ratio
- AMST N/A
- HOTH N/A
- Revenue Growth
- AMST N/A
- HOTH N/A
- 52 Week Low
- AMST $2.00
- HOTH $0.58
- 52 Week High
- AMST $6.27
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- AMST 54.10
- HOTH 64.78
- Support Level
- AMST $2.67
- HOTH $0.88
- Resistance Level
- AMST $3.04
- HOTH $1.78
- Average True Range (ATR)
- AMST 0.29
- HOTH 0.16
- MACD
- AMST -0.02
- HOTH 0.05
- Stochastic Oscillator
- AMST 21.90
- HOTH 50.72
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.